Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody

Charles L Howe, Allan J. Bieber, Arthur E. Warrington, Larry R Pease, Moses Rodriguez

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Stabilizing the survival of oligodendrocytes and oligodendrocyte precursors within and near lesions in patients suffering from multiple sclerosis (MS) and other demyelinating diseases is an important therapeutic goal. Previous studies have identified a human-derived monoclonal IgM antibody designated rHIgM22 that induces remyelination in a mouse model of MS. We provide evidence that this antibody, directed against myelin, induces antiapoptotic signaling in premyelinating oligodendrocytes and reduces caspase-3 activation and caspase gene expression in mice undergoing antibody-induced remyelination. This effect was dependent on calcium entry via CNQX-sensitive channels and on lipid raft integrity, and was correlated with suppression of JNK signaling. We conclude that rHIgM22 may induce remyelination via rescue of oligodendrocytes, and suggest that such autoantibody-mediated signaling may have important therapeutic implications for a variety of neurological diseases, including stroke and Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)120-131
Number of pages12
JournalNeurobiology of Disease
Volume15
Issue number1
DOIs
StatePublished - Feb 2004

Fingerprint

Oligodendroglia
Antibodies
Multiple Sclerosis
6-Cyano-7-nitroquinoxaline-2,3-dione
Demyelinating Diseases
Myelin Sheath
Caspases
Caspase 3
Autoantibodies
Immunoglobulin M
Alzheimer Disease
Stroke
Monoclonal Antibodies
Calcium
Lipids
Gene Expression
Therapeutics

Keywords

  • Apoptosis
  • Autoantibody
  • Demyelinating disease
  • Glia
  • Multiple sclerosis
  • Myelin

ASJC Scopus subject areas

  • Neurology

Cite this

Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. / Howe, Charles L; Bieber, Allan J.; Warrington, Arthur E.; Pease, Larry R; Rodriguez, Moses.

In: Neurobiology of Disease, Vol. 15, No. 1, 02.2004, p. 120-131.

Research output: Contribution to journalArticle

Howe, Charles L ; Bieber, Allan J. ; Warrington, Arthur E. ; Pease, Larry R ; Rodriguez, Moses. / Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. In: Neurobiology of Disease. 2004 ; Vol. 15, No. 1. pp. 120-131.
@article{069a7cc27ffd4ca7959cf6bdac96142c,
title = "Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody",
abstract = "Stabilizing the survival of oligodendrocytes and oligodendrocyte precursors within and near lesions in patients suffering from multiple sclerosis (MS) and other demyelinating diseases is an important therapeutic goal. Previous studies have identified a human-derived monoclonal IgM antibody designated rHIgM22 that induces remyelination in a mouse model of MS. We provide evidence that this antibody, directed against myelin, induces antiapoptotic signaling in premyelinating oligodendrocytes and reduces caspase-3 activation and caspase gene expression in mice undergoing antibody-induced remyelination. This effect was dependent on calcium entry via CNQX-sensitive channels and on lipid raft integrity, and was correlated with suppression of JNK signaling. We conclude that rHIgM22 may induce remyelination via rescue of oligodendrocytes, and suggest that such autoantibody-mediated signaling may have important therapeutic implications for a variety of neurological diseases, including stroke and Alzheimer's disease.",
keywords = "Apoptosis, Autoantibody, Demyelinating disease, Glia, Multiple sclerosis, Myelin",
author = "Howe, {Charles L} and Bieber, {Allan J.} and Warrington, {Arthur E.} and Pease, {Larry R} and Moses Rodriguez",
year = "2004",
month = "2",
doi = "10.1016/j.nbd.2003.09.002",
language = "English (US)",
volume = "15",
pages = "120--131",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody

AU - Howe, Charles L

AU - Bieber, Allan J.

AU - Warrington, Arthur E.

AU - Pease, Larry R

AU - Rodriguez, Moses

PY - 2004/2

Y1 - 2004/2

N2 - Stabilizing the survival of oligodendrocytes and oligodendrocyte precursors within and near lesions in patients suffering from multiple sclerosis (MS) and other demyelinating diseases is an important therapeutic goal. Previous studies have identified a human-derived monoclonal IgM antibody designated rHIgM22 that induces remyelination in a mouse model of MS. We provide evidence that this antibody, directed against myelin, induces antiapoptotic signaling in premyelinating oligodendrocytes and reduces caspase-3 activation and caspase gene expression in mice undergoing antibody-induced remyelination. This effect was dependent on calcium entry via CNQX-sensitive channels and on lipid raft integrity, and was correlated with suppression of JNK signaling. We conclude that rHIgM22 may induce remyelination via rescue of oligodendrocytes, and suggest that such autoantibody-mediated signaling may have important therapeutic implications for a variety of neurological diseases, including stroke and Alzheimer's disease.

AB - Stabilizing the survival of oligodendrocytes and oligodendrocyte precursors within and near lesions in patients suffering from multiple sclerosis (MS) and other demyelinating diseases is an important therapeutic goal. Previous studies have identified a human-derived monoclonal IgM antibody designated rHIgM22 that induces remyelination in a mouse model of MS. We provide evidence that this antibody, directed against myelin, induces antiapoptotic signaling in premyelinating oligodendrocytes and reduces caspase-3 activation and caspase gene expression in mice undergoing antibody-induced remyelination. This effect was dependent on calcium entry via CNQX-sensitive channels and on lipid raft integrity, and was correlated with suppression of JNK signaling. We conclude that rHIgM22 may induce remyelination via rescue of oligodendrocytes, and suggest that such autoantibody-mediated signaling may have important therapeutic implications for a variety of neurological diseases, including stroke and Alzheimer's disease.

KW - Apoptosis

KW - Autoantibody

KW - Demyelinating disease

KW - Glia

KW - Multiple sclerosis

KW - Myelin

UR - http://www.scopus.com/inward/record.url?scp=1642578925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642578925&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2003.09.002

DO - 10.1016/j.nbd.2003.09.002

M3 - Article

VL - 15

SP - 120

EP - 131

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 1

ER -